Evidence map›Paper›PMID 41738205›Full record

ArticleAmerican journal of respiratory cell and molecular biology2026

RUNX1 is a mediator of fibrotic activation and epigenetic memory in lung fibroblasts.

Rachel M Gilbert, Dakota L Jones, Jack Wellmerling, Nunzia Caporarello, Jeffrey A Meridew, Kyoung M Choi, Andrew J Haak, Patrick A Link, Qi Tan, Jeong-Heon Lee and 3 more

Abstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Rachel M GilbertDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, United States.
Dakota L JonesDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, United States.
Jack WellmerlingDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, United States.
Nunzia CaporarelloDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, United States.
Jeffrey A MeridewDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, United States.
Kyoung M ChoiDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, United States.
Andrew J HaakDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, United States.
Patrick A LinkDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, United States.
Qi TanDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, United States.
Jeong-Heon LeeDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, United States.
Tamas OrdogDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, United States.ORCID 0000-0002-3940-7284
Giovanni LigrestiDepartment of Medicine, Boston University School of Medicine, Boston, MA, United States.
Daniel J TschumperlinDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, United States.

Funding

Fibrogenic activation and memory in the lung mesenchymeR01HL166187 · NHLBI · MAYO CLINIC ROCHESTER · PI Daniel J. Tschumperlin · 2023 to 2026
$2.4M
Targeting CEBPA To Restore Epithelial-Mesenchymal Homeostasis In Lung FibrosisR01HL153026 · NHLBI · UNIVERSITY OF MINNESOTA · PI TAN, QI · 2020 to 2024
$2.3M
The role of pleural mesothelium in lung injury, repair, and regenerationF32HL175907 · NHLBI · MAYO CLINIC ROCHESTER · PI Rachel Gilbert · 2024 to 2026
$240k
American Lung Association DAALA2023-1045091Boehringer Ingelheim ILD-DiscoveryNHLBI NIH HHS F32 HL175907NHLBI NIH HHS R01 HL153026NHLBI NIH HHS R01 HL166187NIH HHS DK84567NIH HHS HL142596NIH HHS HL166187NIH HHS HL173656NIH HHS HL175907
6 · The paper itself

Abstract

Repetitive injury is hypothesized to lead to progressive tissue fibrosis and end-stage organ failure. Whether tissue-resident mesenchymal cell populations retain epigenetic memory of prior injuries that contribute to this pathological process is unknown. Here we used a genetic lineage labeling approach to mark the lung mesenchyme prior to injury, then performed multimodal analyses on isolated lung mesenchyme during the initiation, progression, and resolution of the fibrotic response. Our results demonstrate the remarkable epigenetic and transcriptional plasticity of the lung mesenchyme during fibrotic activation and de-activation. Despite this plasticity, we also find that the lung mesenchyme exhibits an enhanced fibrotic program upon reinjury. We identify RUNX1 as a critical driver of both fibrotic activation and fibrotic memory. Comparison of fresh isolated and cultured lung mesenchyme demonstrates that RUNX1 is spontaneously activated in standard culture conditions, previously masking these roles of RUNX1. Targeted knockdown of RUNX1 dampens fibrotic mesenchymal cell activation immediately after cell isolation, but with reduced efficacy after only days of culture, confirming its functional importance to both early activation and long-term memory. Collectively, our findings implicate RUNX1 in the initiation and memory of fibrotic mesenchymal cell activation that together prime enhanced mesenchymal cell responses upon repeated injury.

Indexed as

Core Binding Factor Alpha 2 SubunitEpigenesis, GeneticFibroblastsLungPulmonary FibrosisAnimalsCells, CulturedEpigenetic MemoryFibrosisMesenchymal Stem CellsMesodermMiceMice, Inbred C57BLCore Binding Factor Alpha 2 SubunitRunx1 protein, mouseATACseqChIPseqlung fibrosismulti-omicsRNAseq

Identifiers

PMID41738205
PMCPMC13316937

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.